146 related articles for article (PubMed ID: 12611732)
1. Effects of phospholipid-coated extracorporeal circuits on clinical outcome parameters and systemic inflammatory response in coronary artery bypass graft patients.
Schulz CM; Pritisanac A; Schütz A; Kilger E; Platzer H; Reichart B; Wildhirt SM
Heart Surg Forum; 2002; 6(1):47-52. PubMed ID: 12611732
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting.
Schulze C; Conrad N; Schütz A; Egi K; Reichenspurner H; Reichart B; Wildhirt SM
Thorac Cardiovasc Surg; 2000 Dec; 48(6):364-9. PubMed ID: 11145406
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biomaterial evaluation of a new condensed dual-function extracorporeal circuit in reoperation for coronary artery bypass surgery.
Gunaydin S; McCusker K; Vijay V
Int J Artif Organs; 2009 Nov; 32(11):802-10. PubMed ID: 20020412
[TBL] [Abstract][Full Text] [Related]
4. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan based heparin free coated open and closed extracorporeal circuits for high risk coronary revascularization.
Gunaydin S; Ucar HI; Serter T; McCusker K; Ozcelik G; Salman N; Yorgancioglu AC
J Extra Corpor Technol; 2010 Dec; 42(4):286-92. PubMed ID: 21313926
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylcholine-coated circuits improve preservation of platelet count and reduce expression of proinflammatory cytokines in CABG: a prospective randomized trial.
Schulze CJ; Han L; Ghorpade N; Etches WS; Stang L; Koshal A; Wang SH
J Card Surg; 2009; 24(4):363-8. PubMed ID: 19583605
[TBL] [Abstract][Full Text] [Related]
8. Non-extracorporeal circulation for coronary artery bypass graft surgery is more beneficial than extracorporeal circulation.
Yang FY; Bao YZ; Liu FS; Zhu YC; Zheng J; Zhang JH; Zheng XF; Wei GC
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1452-6. PubMed ID: 25967721
[TBL] [Abstract][Full Text] [Related]
9. Myocardial revascularization with miniaturized extracorporeal circulation versus off pump: Evaluation of systemic and myocardial inflammatory response in a prospective randomized study.
Formica F; Broccolo F; Martino A; Sciucchetti J; Giordano V; Avalli L; Radaelli G; Ferro O; Corti F; Cocuzza C; Paolini G
J Thorac Cardiovasc Surg; 2009 May; 137(5):1206-12. PubMed ID: 19379993
[TBL] [Abstract][Full Text] [Related]
10. Modulating IL-6 and IL-10 levels by pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery.
Harig F; Hohenstein B; von der Emde J; Weyand M
Shock; 2001; 16 Suppl 1():33-8. PubMed ID: 11770031
[TBL] [Abstract][Full Text] [Related]
11. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study.
Torina AG; Silveira-Filho LM; Vilarinho KA; Eghtesady P; Oliveira PP; Sposito AC; Petrucci O
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):663-70. PubMed ID: 22578899
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and lipid mediator blood concentrations after coronary artery surgery.
Nathan N; Denizot Y; Cornu E; Jauberteau MO; Chauvreau C; Feiss P
Anesth Analg; 1997 Dec; 85(6):1240-6. PubMed ID: 9390587
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination.
Radaelli A; Loardi C; Cazzaniga M; Balestri G; DeCarlini C; Cerrito MG; Cusa EN; Guerra L; Garducci S; Santo D; Menicanti L; Paolini G; Azzellino A; Lavitrano ML; Mancia G; Ferrari AU
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2750-5. PubMed ID: 17823365
[TBL] [Abstract][Full Text] [Related]
14. Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function.
Butler J; Murithi EW; Pathi VL; MacArthur KJ; Berg GA
Ann Thorac Surg; 2002 Jul; 74(1):139-42. PubMed ID: 12118746
[TBL] [Abstract][Full Text] [Related]
15. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation?
Denizot Y; Feiss P; Nathan N
Cytokine; 1999 Apr; 11(4):301-4. PubMed ID: 10328869
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of systemic inflammatory response in cardiovascular surgery via interleukin-6, interleukin-8, and neopterin.
Uyar IS; Onal S; Uysal A; Ozdemir U; Burma O; Bulut V
Heart Surg Forum; 2014 Feb; 17(1):E13-7. PubMed ID: 24631985
[TBL] [Abstract][Full Text] [Related]
17. Hemocompatibility of PMEA coated oxygenators used for extracorporeal circulation procedures.
Zimmermann AK; Aebert H; Reiz A; Freitag M; Husseini M; Ziemer G; Wendel HP
ASAIO J; 2004; 50(3):193-9. PubMed ID: 15171468
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging for the detection of ischemic brain lesions in coronary artery bypass graft surgery: relation to extracorporeal circulation and heparinization.
Mirow N; Zittermann A; Körperich H; Börgermann J; Koertke H; Knobl H; Gieseke J; Ostertun B; Coskun T; Kleesiek K; Burchert W; Gummert JF
J Cardiovasc Surg (Torino); 2011 Feb; 52(1):117-26. PubMed ID: 21224820
[TBL] [Abstract][Full Text] [Related]
19. Minimal versus conventional cardiopulmonary bypass: assessment of intraoperative myocardial damage in coronary bypass surgery.
Immer FF; Pirovino C; Gygax E; Englberger L; Tevaearai H; Carrel TP
Eur J Cardiothorac Surg; 2005 Nov; 28(5):701-4. PubMed ID: 16221550
[TBL] [Abstract][Full Text] [Related]
20. Heparin coating with aprotinin reduces blood activation during coronary artery operations.
Baufreton C; Jansen PG; Le Besnerais P; te Velthuis H; Thijs CM; Wildevuur CR; Loisance DY
Ann Thorac Surg; 1997 Jan; 63(1):50-6. PubMed ID: 8993240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
